Sandler Capital Management’s Boston Scientific BSX Stock Holding History

Sandler Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,004	Closed	-$1.76M	–	148
2025 Q3	$1.76M	Buy	18,004 +2,089	+13%	+$216K	0.52%	76
2025 Q2	$1.71M	Sell	15,915 -25,867	-62%	-$2.62M	0.46%	91
2025 Q1	$4.21M	Buy	41,782 +6,605	+19%	+$665K	1.05%	34
2024 Q4	$3.14M	Sell	35,177 -21,062	-37%	-$1.85M	0.33%	106
2024 Q3	$4.71M	Buy	56,239 +4,267	+8%	+$336K	0.62%	67
2024 Q2	$4M	Sell	51,972 -20,270	-28%	-$1.48M	0.43%	84
2024 Q1	$4.95M	Sell	72,242 -334,670	-82%	-$21.5M	0.36%	98
2023 Q4	$23.5M	Buy	406,912 +22,233	+6%	+$1.19M	1.95%	11
2023 Q3	$20.3M	Sell	384,679 -112,079	-23%	-$5.88M	2.09%	9
2023 Q2	$26.9M	Buy	496,758 +143,645	+41%	+$7.5M	2.21%	12
2023 Q1	$17.7M	Buy	+353,113	New	+$16.6M	1.61%	19

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sandler Capital Management's BSX Position: Q4 2025 in Review

Sandler Capital Management sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 18,004 shares — an estimated $1.76M sold.

Sandler Capital Management first reported a position in BSX in Q1 2023 and held it in 11 quarters. The position peaked at $26.9M in Q2 2023. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Sandler Capital Management reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Sandler Capital Management sold 18,004 Boston Scientific shares in Q4 2025, an estimated $1.76M.
Sandler Capital Management first reported a position in Boston Scientific in Q1 2023 and held it in 11 quarters.
Sandler Capital Management's Boston Scientific position peaked at $26.9M in Q2 2023.
1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Sandler Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.